Thu, December 5, 2019
Wed, December 4, 2019
Tue, December 3, 2019
Mon, December 2, 2019
Fri, November 29, 2019
Wed, November 27, 2019

Mohit Bansal Upgraded (BOLD) to Hold and Increased Target to $60 on, Dec 3rd, 2019

Mohit Bansal of Citigroup, Upgraded "Boundless Bio, Inc." (BOLD) to Hold and Increased Target from $30 to $60 on, Dec 3rd, 2019.

Mohit has made no other calls on BOLD in the last 4 months.



There is 1 other peer that has a rating on BOLD. Out of the 1 peers that are also analyzing BOLD, 0 agree with Mohit's Rating of Hold.



This is the rating of the analyst that currently disagrees with Mohit


  • Josh Schimmer of "Evercore ISI Group" Upgraded from Hold to Buy and Held Target at $40 on, Tuesday, November 19th, 2019